https://pubmed.ncbi.nlm.nih.gov/38114073

The KetECT and ELEKT-D trials on major depressive disorder found significant differences in remission rates between ketamine and electroconvulsive therapy (ECT), suggesting the need for personalized treatments and identifying suitable candidates for each intervention.